MAPT and Mental deterioration: A study conducted by Kleineidam and colleagues found that Tau can bind to the SH3 domain of PLCγ2 and that P522R, a protective variant of PLCG2, can reduce p-Tau levels in cerebrospinal fluid and delay cognitive decline in individuals with MCI.